Complications in Cancer Diagnosis and Treatment
At PneumoNIX Medical, we recognize the complex challenges that arise during cancer diagnosis and treatment. Complications can impact patient outcomes significantly. That’s why we are committed to improving cancer care by tackling these complexities head-on.
Our mission is to solve the intricate challenges associated with cancer diagnosis and treatment, revolutionizing the field with innovative hydrogel based solutions. Join us as we embark on this journey to elevate cancer care.
To begin, we have identified three complications which can be solved with our technology platform.
Pneumothorax
LUNG BIOPSY
Pneumothorax: Air leakage causing lung collapse during percutaneous lung biopsy. Occurrence: Happens in 12-45% of 1.3M annual procedures worldwide. Impact: Asymptomatic cases require extended observation, symptomatic cases convert to inpatient overnight stay. Consequences: Significant patient morbidity, physician fatigue, and hospital resource utilization.
Hemorrhage
RENAL BIOPSY
Hemorrhage: Major blood vessels punctured during biopsy lead to severe bleeding Occurrence: Happens in 5-7% of renal biopsies. Impact: May require blood perfusion, surgical/radiological intervention, or may lead to death. Consequences: Significant patient morbidity and mortality.
Non-Target Embolization
TARE/TACE/PAE
Non-Target Embolization: Presence of collateral vessels or reflux can lead to unintended embolization. Occurrence: Dependent on embolization procedure (4-7%). Impact: Dependent on procedure (mucosal ulcerations in TACE, GU side effects in PAE) Consequences: Significant patient morbidity and mortality.
Tunable Hydrogel Technology Platform
Discover the limitless potential of our proprietary tunable hydrogel technology platform. Designed for cancer care, our innovative platform offers customizable hydrogels that can be tailored precisely to specific applications. With rapid resorption in minutes to days, our hydrogels require no preparation, ensuring seamless and efficient use.
See how we are preventing pneumothorax with our hydrogel and unique intra-operative delivery
SUPPORTED BY
